Search Results - "Bohn, Martha C"

Refine Results
  1. 1

    The "Perivascular Pump" Driven by Arterial Pulsation is a Powerful Mechanism for the Distribution of Therapeutic Molecules within the Brain by Hadaczek, Piotr, Yamashita, Yoji, Mirek, Hanna, Tamas, Laszlo, Bohn, Martha C, Noble, Charles, Park, John W, Bankiewicz, Krystof

    Published in Molecular therapy (01-07-2006)
    “…We investigated the movement of interstitially infused macromolecules within the central nervous system (CNS) in rats with high and low blood pressure…”
    Get full text
    Journal Article
  2. 2

    AAV2 mediated retrograde transduction of corticospinal motor neurons reveals initial and selective apical dendrite degeneration in ALS by Jara, Javier H, Villa, Stephanie R, Khan, Nabil A, Bohn, Martha C, Özdinler, P. Hande

    Published in Neurobiology of disease (01-08-2012)
    “…Abstract Corticospinal motor neurons (CSMN) are the cortical component of motor neuron circuitry, which controls voluntary movement and degenerates in diseases…”
    Get full text
    Journal Article
  3. 3

    Glial cell line-derived neurotrophic factor-secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease by Glavaski-Joksimovic, Aleksandra, Virag, Tamas, Mangatu, Thomas A., McGrogan, Michael, Wang, Xue Song, Bohn, Martha C.

    Published in Journal of neuroscience research (01-09-2010)
    “…Parkinson's disease (PD) is a neurodegenerative disease characterized by progressive degeneration of nigrostriatal dopaminergic (DA) neurons. The therapeutic…”
    Get full text
    Journal Article
  4. 4

    Novel Magnetic Hydroxyapatite Nanoparticles as Non-Viral Vectors for the Glial Cell Line-Derived Neurotrophic Factor Gene by Wu, Hsi-Chin, Wang, Tzu-Wei, Bohn, Martha C., Lin, Feng-Huei, Spector, Myron

    Published in Advanced functional materials (08-01-2010)
    “…Nanoparticles (NPs) of synthetic hydroxyapatite (Hap) and natural bone mineral (NBM) are rendered magnetic by treatment with iron ions using a wet‐chemical…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors by Glavaski-Joksimovic, Aleksandra, Virag, Tamas, Chang, Qin A, West, Neva C, Mangatu, Thomas A, McGrogan, Michael P, Dugich-Djordjevic, Millicent, Bohn, Martha C

    Published in Cell transplantation (01-01-2009)
    “…Parkinson's disease (PD) is a common neurodegenerative disease characterized by the selective loss of dopaminergic (DA) neurons in the midbrain. Various types…”
    Get full text
    Journal Article
  7. 7

    Mesenchymal stem cells and neuroregeneration in Parkinson's disease by Glavaski-Joksimovic, Aleksandra, Bohn, Martha C.

    Published in Experimental neurology (01-09-2013)
    “…Parkinson's disease (PD) is a prevalent neurodegenerative disorder characterized by a progressive and extensive loss of dopaminergic (DA) neurons in the…”
    Get full text
    Journal Article
  8. 8

    Dopaminergic Neurons Protected from Degeneration by GDNF Gene Therapy by Choi-Lundberg, Derek L., Lin, Qing, Chang, Yung-Nien, Chiang, Yawen L., Hay, Carl M., Mohajeri, Hasan, Davidson, Beverly L., Bohn, Martha C.

    “…Glial cell line-derived neurotrophic factor (GDNF) supports growth and survival of dopaminergic (DA) neurons. A replication-defective adenoviral (Ad) vector…”
    Get full text
    Journal Article
  9. 9

    Targeting alpha-synuclein with a microRNA-embedded silencing vector in the rat substantia nigra: Positive and negative effects by Khodr, Christina E, Becerra, Amanda, Han, Ye, Bohn, Martha C

    Published in Brain research (06-03-2014)
    “…Abstract Background : Alpha-synuclein (SNCA) downregulation shows therapeutic potential for synucleinopathies, including Parkinson’s disease (PD). Previously…”
    Get full text
    Journal Article
  10. 10

    Corticospinal Motor Neurons Are Susceptible to Increased ER Stress and Display Profound Degeneration in the Absence of UCHL1 Function by Jara, Javier H, Genç, Barış, Cox, Gregory A, Bohn, Martha C, Roos, Raymond P, Macklis, Jeffrey D, Ulupınar, Emel, Özdinler, P Hande

    Published in Cerebral cortex (New York, N.Y. 1991) (01-11-2015)
    “…Corticospinal motor neurons (CSMN) receive, integrate, and relay cerebral cortex's input toward spinal targets to initiate and modulate voluntary movement…”
    Get full text
    Journal Article
  11. 11

    Glial Cell Line-Derived Neurotrophic Factor (GDNF) Gene Delivery Protects Dopaminergic Terminals from Degeneration by Connor, Bronwen, Kozlowski, Dorothy A., Unnerstall, James R., Elsworth, John D., Tillerson, Jennifer L., Schallert, Timothy, Bohn, Martha C.

    Published in Experimental neurology (01-05-2001)
    “…Previously, we observed that injection of an adenoviral (Ad) vector expressing glial cell line-derived neurotrophic factor (GDNF) into the striatum, but not…”
    Get full text
    Journal Article
  12. 12

    A microRNA embedded AAV alpha-synuclein gene silencing vector for dopaminergic neurons by Han, Ye, Khodr, Christina E, Sapru, Mohan K, Pedapati, Jyothi, Bohn, Martha C

    Published in Brain research (22-04-2011)
    “…Abstract Alpha-synuclein (SNCA), an abundantly expressed presynaptic protein, is implicated in Parkinson's disease (PD). Since over-expression of human SNCA…”
    Get full text
    Journal Article
  13. 13

    Motoneurons crave glial cell line-derived neurotrophic factor by Bohn, Martha C.

    Published in Experimental neurology (01-12-2004)
    “…This is a commentary on the developmental and therapeutic relevance of recent studies in the glial fibrillary acid protein (GFAP)-glial cell line-derived…”
    Get full text
    Journal Article
  14. 14

    Silencing of human α-synuclein in vitro and in rat brain using lentiviral-mediated RNAi by Sapru, Mohan K., Yates, Jonathan W., Hogan, Shea, Jiang, Lixin, Halter, Jeremy, Bohn, Martha C.

    Published in Experimental neurology (01-04-2006)
    “…Human α-synuclein overexpression and its toxic accumulation in neurons or glia are known to play key roles in the pathogenesis of Parkinson's disease and other…”
    Get full text
    Journal Article
  15. 15

    Inclusion of a portion of the native SNCA 3'UTR reduces toxicity of human S129A SNCA on striatal-projecting dopamine neurons in rat substantia nigra by Khodr, Christina E, Pedapati, Jyothi, Han, Ye, Bohn, Martha C

    Published in Developmental neurobiology (Hoboken, N.J.) (01-06-2012)
    “…Experimental models of Parkinson's disease (PD) created by aberrant expression of the alpha-synuclein (SNCA) coding region have been reported. However,…”
    Get full text
    Journal Article
  16. 16

    Hypothalamic IGF-I Gene Therapy Prolongs Estrous Cyclicity and Protects Ovarian Structure in Middle-Aged Female Rats by Rodríguez, Silvia S, Schwerdt, José I, Barbeito, Claudio G, Flamini, Mirta A, Han, Ye, Bohn, Martha C, Goya, Rodolfo G

    Published in Endocrinology (Philadelphia) (01-06-2013)
    “…There is substantial evidence that age-related ovarian failure in rats is preceded by abnormal responsiveness of the neuroendocrine axis to estrogen positive…”
    Get full text
    Journal Article
  17. 17

    An alpha-synuclein AAV gene silencing vector ameliorates a behavioral deficit in a rat model of Parkinson's disease, but displays toxicity in dopamine neurons by Khodr, Christina E, Sapru, Mohan K, Pedapati, Jyothi, Han, Ye, West, Neva C, Kells, Adrian P, Bankiewicz, Krystof S, Bohn, Martha C

    Published in Brain research (13-06-2011)
    “…Abstract Effects of silencing ectopically expressed hSNCA in rat substantia nigra (SN) were examined as a novel therapeutic approach to Parkinson's disease…”
    Get full text
    Journal Article
  18. 18

    Progressive degeneration of dopamine neurons in 6-hydroxydopamine rat model of parkinson's disease does not involve activation of caspase-9 and caspase-3 by Ebert, Allison D., Hann, Hoo Jae, Bohn, Martha C.

    Published in Journal of neuroscience research (01-02-2008)
    “…6‐Hydroxydopamine (6‐OHDA), a neurotoxin that causes the death of dopamine (DA) neurons, is commonly used to produce experimental models of Parkinson's disease…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Non-viral delivery of the gene for glial cell line-derived neurotrophic factor to mesenchymal stem cells in vitro via a collagen scaffold by Bolliet, Catherine, Bohn, Martha C, Spector, Myron

    Published in Tissue engineering. Part C, Methods (01-09-2008)
    “…Recent advances in tissue engineering that combine an extracellular matrix-like scaffold with therapeutic molecules, cells, DNA encoding therapeutic proteins,…”
    Get more information
    Journal Article